FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

FOR 2240 scientists receive several honors at ARVO 2022

FOR 2240 ARVO 2022

FOR 2240 ARVO 2022

The scientist of the DFG research group 2240 again had a strong presence at the annual ARVO conference in 2022. ARVO is the largest organization for eye and vision research worldwide. The conference took place in person in Denver, Colorado from 1st – 4th May and virtually from 11th – 12th May 2022. In total 17 FOR 2240 members took part in this year´s conference, of which 14 attended in person and three participated online.

Five of our scientists received ARVO travel grants endowed with USD 1100 supporting them to  present their latest work on-site in Denver. Namely Alfrun Schönberg (AG Bock, DFG Research grant), Antonia Howaldt (Cologne Clinician Scientist Program (CCSP)), Thomas Volatier (AG Notara, FOR 2240 TP N2), Wei Zhang (AG Cursiefen, FOR 2240 TP1) and Mert Mestanoglu (AG Cursiefen/Bock, Studienstiftung des deutschen Volkes).

Further to this, two of our scientist´s projects have been identified by members of the Annual Meeting Program Committee as “Hot Topic” representing the newest and most innovative research at the ARVO: Alfrun Schönberg (AG Bock) presented a talk on the “Effect of sCD83 on direct allosensitization after corneal transplantation” elucidating how the corneal graft itself can be used to improve corneal graft survival. Dr. Matthias Hamdorf (AG Bock/Cursiefen) presented a poster on “Aflibercept (Eylea) inhibits dendritic cell migration” shedding light on the complex interaction of the well-known antiangiogenic therapeutic and the immune system.

In addition, Dr. Leonie Mengesha (Supervision: Prof. Bachmann) won second place in the Théa Trophy Contest for her project “Novel surgical approaches in complex situations: when ocular cicatricial pemphigoid and glaucoma collide”. The Théa Trophy symposium is held during the ARVO annual meeting and is designed to encourage presentation and communication skills of residents and fellows in ophthalmology and gives young ophthalmologist the chance to present their work to larger audiences.

Related posts

January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more
November 22, 2022

4th Shanghai-Cologne Scientific Symposium


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck